In line with these findings, low Mfn2 expression in breast cancer patients is associated with poor outcome, and overexpression of Mfn2 was shown to induce apoptosis in a hepatocellular carcinoma model [65,82,83,84]. This evidence concerns the gene MFN2 and hepatocellular carcinoma.